SCHEMBL23028569

SCHEMBL23028569

O=NCCC(=O)OCCc1ncno1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.32
APP P05067 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23028566 0.87
SCHEMBL23028565 0.82 TDP1 (0.37) TDP1APP
SCHEMBL23028563 0.79
SCHEMBL23028650 0.78 POLB (0.30)
SCHEMBL23028561 0.74 CES1 (0.32)
SCHEMBL23028570 0.74 CYP2D6 (0.34)
SCHEMBL23028652 0.71 ALDH1A1 (0.31) TDP1
SCHEMBL15333044 0.68 RXRA (0.41)
SCHEMBL23028644 0.67 ALDH1A1 (0.51)
SCHEMBL23028593 0.67 TDP1 (0.33) TDP1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021034548-A1 MITOCHONDRIAL MODULATION TO IMPROVE METABOLIC SYNDROME DURING AGING THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-02-25 WO disclosed